Photodynamic therapy of basal cell carcinoma of the face H-zone

This article reviews clinical experience in treating skin neoplasms using photodynamic therapy with combined ultrasound and fluorescence diag- nostics for neoplasms in the nose, lateral face, and adjacent areas. Injectable forms of chlorine-type drugs were used as photosensitizers – photodi- tazine...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Nadkernichnaya, M. V. Ermoschenkova, V. E. Semin, S. A. Parts, V. N. Galkin, I. V. Reshetov
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2025-07-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/719
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409375390662656
author E. V. Nadkernichnaya
M. V. Ermoschenkova
V. E. Semin
S. A. Parts
V. N. Galkin
I. V. Reshetov
author_facet E. V. Nadkernichnaya
M. V. Ermoschenkova
V. E. Semin
S. A. Parts
V. N. Galkin
I. V. Reshetov
author_sort E. V. Nadkernichnaya
collection DOAJ
description This article reviews clinical experience in treating skin neoplasms using photodynamic therapy with combined ultrasound and fluorescence diag- nostics for neoplasms in the nose, lateral face, and adjacent areas. Injectable forms of chlorine-type drugs were used as photosensitizers – photodi- tazine or photoran at a dose of 0.7 to 2.5 mg per kilogram of patient body weight. The drug was administered intravenously for 30 minutes 2.5-3.0 hours before tumor irradiation. Of 107 observations over a 9-month observation period, one case of marginal tumor recurrence in the treatment area was detected. Thus, the recurrence rate was 0.93%. The results show that three-dimensional tumor visualization for the H-zone with complex noninvasive diagnostics allows achieving high efficiency in photodynamic therapy of non-melanoma tumors of the above anatomical localizations.
format Article
id doaj-art-9cf28a04232644e6818ea0f0f3bf7931
institution Kabale University
issn 2413-9432
language Russian
publishDate 2025-07-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-9cf28a04232644e6818ea0f0f3bf79312025-08-20T03:35:32ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322025-07-0114210.24931/2413-9432-2025-14-2-27-30318Photodynamic therapy of basal cell carcinoma of the face H-zoneE. V. Nadkernichnaya0M. V. Ermoschenkova1V. E. Semin2S. A. Parts3V. N. Galkin4I. V. Reshetov5State Budgetary Healthcare Institution of the City of Moscow “S.S. Yudin City Clinical Hospital of the Moscow City Healthcare Department”State Budgetary Healthcare Institution of the City of Moscow “S.S. Yudin City Clinical Hospital of the Moscow City Healthcare Department”; First Moscow State Medical University named after I.M. SechenovState Budgetary Healthcare Institution of the City of Moscow “S.S. Yudin City Clinical Hospital of the Moscow City Healthcare Department”State Budgetary Healthcare Institution of the City of Moscow “S.S. Yudin City Clinical Hospital of the Moscow City Healthcare Department”State Budgetary Healthcare Institution of the City of Moscow “S.S. Yudin City Clinical Hospital of the Moscow City Healthcare Department”First Moscow State Medical University named after I.M. SechenovThis article reviews clinical experience in treating skin neoplasms using photodynamic therapy with combined ultrasound and fluorescence diag- nostics for neoplasms in the nose, lateral face, and adjacent areas. Injectable forms of chlorine-type drugs were used as photosensitizers – photodi- tazine or photoran at a dose of 0.7 to 2.5 mg per kilogram of patient body weight. The drug was administered intravenously for 30 minutes 2.5-3.0 hours before tumor irradiation. Of 107 observations over a 9-month observation period, one case of marginal tumor recurrence in the treatment area was detected. Thus, the recurrence rate was 0.93%. The results show that three-dimensional tumor visualization for the H-zone with complex noninvasive diagnostics allows achieving high efficiency in photodynamic therapy of non-melanoma tumors of the above anatomical localizations.https://www.pdt-journal.com/jour/article/view/719ultrasound navigationuorescence diagnosticslaser spectroscopynon-melanoma skin tumorslaser spectroscopynon-invasive monitoring
spellingShingle E. V. Nadkernichnaya
M. V. Ermoschenkova
V. E. Semin
S. A. Parts
V. N. Galkin
I. V. Reshetov
Photodynamic therapy of basal cell carcinoma of the face H-zone
Biomedical Photonics
ultrasound navigation
uorescence diagnostics
laser spectroscopy
non-melanoma skin tumors
laser spectroscopy
non-invasive monitoring
title Photodynamic therapy of basal cell carcinoma of the face H-zone
title_full Photodynamic therapy of basal cell carcinoma of the face H-zone
title_fullStr Photodynamic therapy of basal cell carcinoma of the face H-zone
title_full_unstemmed Photodynamic therapy of basal cell carcinoma of the face H-zone
title_short Photodynamic therapy of basal cell carcinoma of the face H-zone
title_sort photodynamic therapy of basal cell carcinoma of the face h zone
topic ultrasound navigation
uorescence diagnostics
laser spectroscopy
non-melanoma skin tumors
laser spectroscopy
non-invasive monitoring
url https://www.pdt-journal.com/jour/article/view/719
work_keys_str_mv AT evnadkernichnaya photodynamictherapyofbasalcellcarcinomaofthefacehzone
AT mvermoschenkova photodynamictherapyofbasalcellcarcinomaofthefacehzone
AT vesemin photodynamictherapyofbasalcellcarcinomaofthefacehzone
AT saparts photodynamictherapyofbasalcellcarcinomaofthefacehzone
AT vngalkin photodynamictherapyofbasalcellcarcinomaofthefacehzone
AT ivreshetov photodynamictherapyofbasalcellcarcinomaofthefacehzone